Next report date
Report period
Q2 2024
EPS estimate
−0.38EUR
Revenue estimate
125.80 MEUR
−1.675EUR
−187.58 MEUR
461.47 MEUR
96.75 M
About NovoCure Limited
Sector
Industry
CEO
Asaf Danziger
Website
Headquarters
St. Helier
Employees (FY)
1.45 K
Founded
2000
ISIN
JE00BYSS4X48
FIGI
BBG00M4R3P62
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NOVOCURE LTD stocks are traded under the ticker 038.
NOVOCURE LTD is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
038 earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.47 EUR resulting in a 13.70% surprise. The estimated earnings for the next quarter are −0.39 EUR per share. See more details about NOVOCURE LTD earnings.
NOVOCURE LTD revenue for the last quarter amounts to 121.21 M EUR despite the estimated figure of 121.22 M EUR. In the next quarter revenue is expected to reach 121.82 M EUR.
Yes, you can track NOVOCURE LTD financials in yearly and quarterly reports right on TradingView.
038 net income for the last quarter is −35.92 M EUR, while the quarter before that showed −42.65 M EUR of net income which accounts for 15.78% change. Track more NOVOCURE LTD financial stats to get the full picture.
No, 038 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 038 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOCURE LTD stock right from TradingView charts — choose your broker and connect to your account.
As of May 6, 2024, the company has 1.45 K employees. See our rating of the largest employees — is NOVOCURE LTD on this list?
We've gathered analysts' opinions on NOVOCURE LTD future price: according to them, 038 price has a max estimate of 39.17 EUR and a min estimate of 13.52 EUR. Watch 038 chart and read a more detailed NOVOCURE LTD stock forecast: see what analysts think of NOVOCURE LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVOCURE LTD EBITDA is −180.11 M EUR, and current EBITDA margin is −42.25%. See more stats in NOVOCURE LTD financial statements.